(Información remitida por la empresa firmante)
Zinzino group revenue increased with a total of 35 %, compared with the previous year.
GOTHENBURG, Sweden, Aug. 3, 2023 /PRNewswire/ — The revenue in July for Zinzino’s sales markets increased by 34 % and amounted to SEK 143.9 (107.2) million. Faun Pharma’s external sales increased by 58 % and amounted to SEK 5.2 (3.3) million. Overall, the Group increased revenues by 35 % to SEK 149.1 (110.5) million compared with the previous year.
Accumulated revenue for January – July 2023 increased by 23 % to SEK 950.9 (774.4) million.
Revenues were distributed as follows:
Countries in regions:
–The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
–Central Europe: Austria, Germany, Switzerland
–East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
–South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Turkey
–The Baltics: Estonia, Latvia, Lithuania
–North America: Canada, USA
–Asia-Pacific: Australia, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand
–Africa: South Africa
For more information:
Dag Bergheim Pettersen CEO Zinzino +47 (0) 932 25 700, zinzino.com
Pictures for publication free of charge:
marketing@zinzino.com
Certified Adviser:Erik Penser Bank Aktiebolag, +46 (0) 8 463 83 00, email: certifiedadviser@penser.se
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/zinzino-ab-publ-preliminary-sales-report-july-2023-301892516.html